Aidy
AboutFeaturesLearnTrials

Partners

Patient ServicesMedical Affairs & HEORSpecialty PharmaciesGI Providers

Category

Biologics & Advanced Therapies

Modern targeted treatments for moderate-severe IBD

Tysabri vs Tremfya for Crohn's Disease: Key Differences
Biologics & Advanced TherapiesAug 14, 2025

Tysabri vs Tremfya for Crohn's Disease: Key Differences

Tysabri vs Tremfya for Crohn's: compare efficacy, PML risk, TOUCH restrictions, and IV vs at-home dosing so you can discuss options with your GI.

Tysabri vs Stelara for Crohn's Disease: How They Compare
Biologics & Advanced TherapiesAug 13, 2025

Tysabri vs Stelara for Crohn's Disease: How They Compare

Tysabri vs Stelara for Crohn’s: compare efficacy, safety, dosing, PML risk and TOUCH restrictions, and learn why Stelara is usually tried first.

Tysabri vs Skyrizi for Crohn's Disease: Which to Choose?
Biologics & Advanced TherapiesAug 12, 2025

Tysabri vs Skyrizi for Crohn's Disease: Which to Choose?

Tysabri vs Skyrizi for Crohn's: compare efficacy, PML risk, TOUCH restrictions and dosing to prepare for a shared decision with your GI.

Tysabri vs Remicade for Crohn's Disease: Key Differences
Biologics & Advanced TherapiesAug 11, 2025

Tysabri vs Remicade for Crohn's Disease: Key Differences

Compare Tysabri and Remicade for Crohn's by efficacy, PML risk, TOUCH access, infusion schedules and dose flexibility to prepare for your GI visit.

Tysabri vs Omvoh for Crohn's Disease: A Comparison
Biologics & Advanced TherapiesAug 10, 2025

Tysabri vs Omvoh for Crohn's Disease: A Comparison

Tysabri vs Omvoh for Crohn's: compare efficacy, PML risk, TOUCH restrictions, and IV vs at-home dosing to prepare for a treatment talk with your GI.

Tysabri vs Humira for Crohn's Disease: A Comparison
Biologics & Advanced TherapiesAug 9, 2025

Tysabri vs Humira for Crohn's Disease: A Comparison

Tysabri vs Humira for Crohn's: compare efficacy, PML risk, TOUCH monitoring, home injections and IV infusions to discuss your options with your GI.

Tysabri vs Entyvio for Crohn's: Comparing Integrin Biologics
Biologics & Advanced TherapiesAug 8, 2025

Tysabri vs Entyvio for Crohn's: Comparing Integrin Biologics

Tysabri vs Entyvio for Crohn's: compare PML risk, TOUCH rules, and 4- vs 8-week maintenance dosing, then prepare key questions for your GI.

Tysabri vs Cimzia for Crohn's Disease: A Patient Guide
Biologics & Advanced TherapiesAug 7, 2025

Tysabri vs Cimzia for Crohn's Disease: A Patient Guide

Tysabri vs Cimzia for Crohn's: compare efficacy, PML risk, pregnancy considerations, and IV infusions vs home injections before your GI visit.

Tremfya vs Stelara for Ulcerative Colitis: Key Comparison
Biologics & Advanced TherapiesAug 6, 2025

Tremfya vs Stelara for Ulcerative Colitis: Key Comparison

Tremfya vs Stelara for ulcerative colitis: compare week 12 efficacy, p19 vs p40 targeting, dosing, safety and cost to guide your GI visit.

Tremfya vs Stelara for Crohn's Disease: GALAXI Trial
Biologics & Advanced TherapiesAug 5, 2025

Tremfya vs Stelara for Crohn's Disease: GALAXI Trial

Tremfya vs Stelara for Crohn's: compare GALAXI results, including 44% to 46% vs about 30% endoscopic response, safety and dosing. See who may benefit.

Tremfya vs Remicade for Ulcerative Colitis: Patient Guide
Biologics & Advanced TherapiesAug 4, 2025

Tremfya vs Remicade for Ulcerative Colitis: Patient Guide

Tremfya vs Remicade for ulcerative colitis: compare QUASAR and ACT evidence, onset, safety, IV vs SC dosing, costs and switching with your GI.

Tremfya vs Remicade for Crohn's: Comparing Biologics
Biologics & Advanced TherapiesAug 3, 2025

Tremfya vs Remicade for Crohn's: Comparing Biologics

Tremfya vs Remicade for Crohn's: compare onset, safety, IV vs SC dosing, switching and biosimilar costs to make an informed choice with your GI.